Capital International Investors Revance Therapeutics, Inc. Transaction History

Capital International Investors

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$11.52 - $20.4 $17.8 Million - $31.5 Million	-1,545,630 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$24.03 - $29.97 $9.22 Million - $11.5 Million	383,730 Added 33.03%	1,545,630 $43.2 Million
Q4 2019 Feb 18, 2020	BUY	$11.66 - $20.15 $9.76 Million - $16.9 Million	836,900 Added 257.51%	1,161,900 $18.9 Million
Q3 2018 Nov 14, 2018	BUY	$23.55 - $30.1 $7.65 Million - $9.78 Million	325,000 New	325,000 $8.08 Million

233

82.1M

680K

896K

Ticker RVNC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 82,305,696
Market Cap $212M
Description
Revance Therapeutics, Inc., a biotechnology company, engages in the development, manufacture, and commercialization of neuromodulators for various aesthetic and therapeutic indications in the United States and internationally. The company's lead drug candidate is DaxibotulinumtoxinA for injection, which has completed phase III clinical trials fo...

Get notified when there are updates to the investment portfolio of Capital International Investors, based on Form 13F filings with the SEC.

Stay updated on Capital International Investors with notifications on news.